Short Ideas - After much anticipation over the last few weeks, Delcath Systems (NASDAQ:DCTH) announced Monday that the New Drug Application for its CHEMOSAT hepatic chemosaturation system has … Continue Reading
Read NowLong Ideas - Elan Corp. (NYSE:ELN) is facing headwinds Monday morning after an analyst downgraded the stock based on slowing Tysabri sales growth. Leerink Swann lowered ELN’s price … Continue Reading
Read NowLong Ideas - With Biogen-Idec’s (NASDAQ:BIIB) new multiple sclerosis (MS) treatment, BG-12, approaching a decision by the FDA (PDUFA date December 28th), enthusiasm in the medical community is … Continue Reading
Read NowShort Ideas - Yesterday, Optimer Pharmaceuticals hosted its Analyst Day describing a new lower pricing policy with hospitals to spur demand of Dificid. Our negative view of the … Continue Reading
Read NowShort Ideas - Optimer Pharmaceuticals (NASDAQ:OPTR) is hosting its Analyst Day in NYC this morning and is detailing its new strategy, which includes lowering the price for lead … Continue Reading
Read NowMost Popular - Peregrine Pharmaceuticals (NASDAQ:PPHM) announced more bad news Thursday, after receiving a default notice from lender, Oxford Finance, on Monday. The default on the loan was … Continue Reading
Read NowMost Popular - Questcor Pharmaceuticals (NASDAQ:QCOR) shares are taking another pounding Monday after the company announced in an 8-k that it “became aware of a U.S. government investigation … Continue Reading
Read Now